Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRG-200 KIT in Refractory Overactive Bladder
NCT07391878Phase 2Not yet recruiting
- Sponsor
- Trigone Pharma
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TRG-200 in overactive bladder (OAB), sponsored by Trigone Pharma. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
TRG-200
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07391878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391878.